Xinvento

Xinvento is a Netherlands-based company developing future treatments for congenital hyperinsulinism. Xinvento aims to alleviate the challenges associated with congenital hyperinsulinism (CHI). By developing effective therapies, our focus is on improving the quality of life for CHI patients and their families.